Top Markets
#1 Islamic Coin Islamic Coin +151.53%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#3 Palladium Network Palladium Network +14.30%
#4 clBTC clBTC +12.18%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.58%
#6 OpenEden OpenEden +9.30%
#7 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.83%
#8 Mantle Staked Ether Mantle Staked Ether +8.33%
#9 MarsCoin MarsCoin +8.26%
#10 Mantle Restaked ETH Mantle Restaked ETH +8.10%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.

INFI
Classificação em ações #40134
Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge,... Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme. IPI-549 is undergoing Phase 2 trials for metastatic triple negative breast cancer and urothelial cancer, and Phase 1/1b trials for various solid tumors. The company maintains several strategic partnerships: with Intellikine, Inc. for the discovery, development, and commercialization of PI3K delta and/or gamma isoform-targeting pharmaceuticals; with Verastem, Inc. for the research, development, commercialization, and production of duvelisib and related compounds; and with PellePharm, Inc. to advance and commercialize its hedgehog inhibitor program, IPI-926, which is also a clinical-stage investigational drug. Furthermore, Infinity Pharmaceuticals holds collaborative agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company.
Preço da ação
$0.0039
Última sincronização: 2023-10-27
Valor de mercado
$235.97K
Variação (1 dia)
-13.33%
Variação (1 ano)
0.00%
País
US
Negociar Infinity Pharmaceuticals, Inc. (INFI)

Categoria

Healthcare
Receita da Infinity Pharmaceuticals, Inc. (INFI)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Infinity Pharmaceuticals, Inc., a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Infinity Pharmaceuticals, Inc. de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE